University of Miami’s Gift of 1994 Ibogaine IND to HHS Sets a Standard for Open Science
August 25, 2026
Washington, D.C., August 25, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS)has welcomed the announcement that the University of Miami has gifted the federal government its 1994 …
MAPS Responds to Report of Progress for MDMA-assisted therapy for PTSD with FDA
August 10, 2026
August 10, 2026 — The non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) today responded to an August 9 report by Psychedelic Alpha indicating that Resilient Pharmaceuticals (formerly …
MAPS Announces Agreement with UAB
July 31, 2026
MAPS can now share we have finalized a clinical trial agreement with the University of Alabama, Birmingham, making UAB the first official site for the MJP2 study of inhaled cannabis in the treatment of …
Clinical-Trial Cannabis and Placebo has Been Shipped
July 20, 2026
Following the issuance of an import permit by Health Canada in June 2026, Research Triangle Institute, the contracted licensed distributor for the National Institute on Drug Abuse (NIDA) Drug Supply Program, …
MAPS Publishes Ibogaine Investigator’s Brochure as a Free, Open-Access Resource
June 30, 2026
Washington, D.C., July 7, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS) released an Ibogaine Investigator’s Brochure (IB), a comprehensive scientific and regulatory resource …
Psychedelic Science 2027 Speaker Submission Invites the Field to Bridge Promise and Practice
June 25, 2026
June, 25, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS) announced the opening of speaker submission for Psychedelic Science 2027 (PS27), its flagship conference for psychedelic …
MAPS Statement on the Supreme Court’s Ruling in United States v. Hemani
June 18, 2026
June 18, 2026 — In United States v. Hemani, the U.S. Supreme Court ruled today that the federal government’s prosecution of Ali Hemani under a provision of the Gun Control Act violated the Second …
MAPS Publishes First-of-Its-Kind Literature Review on Psychedelic Healing for People Impacted by the Criminal Legal System
June 2, 2026
Washington, D.C., June 2, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS) today announced its Psychedelics for System-Impacted People (PSIP) project, a research, education, and …
MAPS Announces Dates for Psychedelic Science 2027; Early Bird Registrations Now Open
May 14, 2026
Denver, Colorado; May 13, 2026 —The Multidisciplinary Association for Psychedelic Studies (MAPS) announced that early bird registrations are now open for Psychedelic Science 2027 (PS27), taking place …
MAPS Welcomes Liana Gillooly and Andrew “Mo” Septimus to Board of Directors
May 7, 2026
SAN JOSE, CA; May 7, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS) today announced the addition of Liana Sananda Gillooly and Andrew “Mo” Septimus to its Board of Directors. …
MAPS & State of Colorado Partner to Deliver Free Harm Reduction Training for First Responders
May 5, 2026
DENVER, May 5, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS) announced a partnership with the Colorado Department of Revenue’s Natural Medicine Division to provide MAPS’ …
MAPS Statement on Bipartisan Congressional Letter to FDA
May 4, 2026
Washington DC — Reps. Jack Bergman (R-MI) and Lou Correa (D-CA), co-chairs of the Congressional Psychedelics Advancing Therapies Caucus, led a bipartisan group of 30 members of Congress in a letter to …